Source: http://www.google.com/patents/US8226614?dq=6,034,652
Timestamp: 2018-01-22 19:21:41
Document Index: 268442935

Matched Legal Cases: ['Application No. 2006800475377', 'Application No. 200680038075', 'Application No. 566773', 'Application No. 567891', 'Application No. 2008110940', 'Application No. 2008122063']

Patent US8226614 - Fluid delivery devices, systems and methods - Google Patents
Fluid delivery devices, systems and methods. The fluid delivery devices may be used to delivery fluid (e.g., insulin) to a user. The devices may have one or more inlets, and may be configured for use with an injection device, such as a syringe, and/or with a pump....http://www.google.com/patents/US8226614?utm_source=gb-gplus-sharePatent US8226614 - Fluid delivery devices, systems and methods
Publication number US8226614 B2
Application number US 11/592,719
Also published as CN101389366A, CN101389366B, EP1948267A2, EP1948267A4, US9039660, US20070135774, US20130023834, US20160015892, WO2007056309A2, WO2007056309A3
Publication number 11592719, 592719, US 8226614 B2, US 8226614B2, US-B2-8226614, US8226614 B2, US8226614B2
Inventors Brandon Turner, John Burns, Dan Benzon, Adam Burnight, Brian Highley, Jason Adams, Kraig Kooiman, Clint Taylor
Patent Citations (158), Non-Patent Citations (183), Referenced by (14), Classifications (15), Legal Events (3)
US 8226614 B2
where a portion of the fluid delivery passageway is substantially perpendicular to the engagement surface.
US5839895 Jun 16, 1997 Nov 24, 1998 Fishburne, Jr.; Cotesworth P. Apparatus and methods for the vibrational treatment of oral tissue and dental materials
US5873844 Jan 22, 1997 Feb 23, 1999 Campero; Manuel Method and apparatus for numbing tissue before inserting a needle
US7494481 * Dec 3, 2004 Feb 24, 2009 Medtronic Minimed, Inc. Multi-position infusion set device and process
US7713258 * Sep 5, 2008 May 11, 2010 Calibra Medical, Inc. Disposable infusion device facilitating tissue fold formation for cannula deployment and method
US20040204691 Apr 7, 2004 Oct 14, 2004 Kenji Yashiro Indwelling catheter set
US20050104473 Sep 28, 2004 May 19, 2005 Mitsunobu Yoshida Electrostatic actuator, electrostatic actuator driving method, electromechanical transducer, waveform output device, and electric element
US20060173386 Jan 26, 2005 Aug 3, 2006 Lindquist Sherrill F Injection distraction device
US20060264818 Jul 7, 2006 Nov 23, 2006 Patton Catherine C Infusion device
US20060264900 Jul 7, 2006 Nov 23, 2006 Patton Catherine C Method relating to infusion device
US20060264901 Jul 7, 2006 Nov 23, 2006 Patton Catherine C Method relating to infusion device
US20070049874 Sep 18, 2006 Mar 1, 2007 Patton Catherine C Infusion Device
US20070049875 Sep 18, 2006 Mar 1, 2007 Patton Catherine C Infusion Device
US20070049877 Sep 18, 2006 Mar 1, 2007 Patton Catherine C Infusion Device
US20070088385 Oct 14, 2005 Apr 19, 2007 Perry Eric S Vibrating tourniquet
US20070093756 Sep 18, 2006 Apr 26, 2007 Patton Catherine C Infusion Device
US20070093757 Sep 18, 2006 Apr 26, 2007 Patton Catherine C Infusion Device
CN253864Y Title not available
4 Anderson et al., "The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study." Arch. Intern. Med., 153:841-4, 1993.
5 Dyer et al., "Insuflon Versus Subcutaneous Injection for Cytokine Administration in Children for Cytokine Administration in Children and Adolescents: A Randomized Crossover Study," J. Pediatric Oncology Nursing, 21:79-86, 2004.
6 FDA, Section 510(k) Notification for Viggo Insuflon, Aug. 24, 1998, Silver Spring, Maryland.
7 File History of U.S. Appl. No. 09/110,360, filed Jul. 6, 1998.
8 Graham et al., "Control of Important Clinical Parameters for Patients with Type 2 Diabetes Mellitus," Diabetes,. 51:A-274, 2002 (Abstract No. 1112-P).
9 Hanas and Ludvigsson, "Experience of Pain from Insulin Injections Using Syringes Pens and Indwelling Catheters." Department of Pediatrics, Uddevalla Hospital, Uddevalla Sweden. Abstract. 1989.
10 Hanas and Ludvigsson, "Metabolic control is not altered when using indwelling catheters for insulin injections." Diabetes Care, 17:716-8, 1994.
11 Hanas and Ludvigsson, "Side effects and indwelling times of subcutaneous catheters for insulin injections: a new device for injecting insulin with a minimum of pain in the treatment of insulin-dependent diabetes mellitus." Diabetes Res. Clin. Pract., 10:73-83, 1990.
12 Hanas et al., "Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections." Diabetes Care, 20:487-90, 1997.
13 Hanas et al., "X-ray appearance of the indwelling catheter when using insuflon for insulin injections." Department of Pediatrics Uddevalla Hospital, Uddevalla, Sweden. Abstracts of the 17th Annual Meeting of ISGD, Hormone Research 35:58, 1991.
14 Hanas, "Reducing injection pain in children and adolescents with diabetes: a review of indwelling catheters," Pediatric Diabetes, 5:102, 2004.
15 Heine, "A Randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control," Diabetes Care, Nov. 1, 2002.
16 Henry et al., "Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial." Diabetes Care, 16:21-31, 1993.
17 Hunt et al. "NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance." Diabetes Care, 20:292-8, 1997.
18 Kaar et al., "Insulin Administration via a Subcutaneous Catheter: Effects on absorption," Diabetes Care, 16:1412-1413, 1993.
19 Knip et al., "No evidence of an accelerated absorption of exogenous insulin after using a subcutaneous catheter for 5 days in children with IDDM" Diabetes Care, Jun. 17:627, 1994.
20 Koro et al., "Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report," Diabetes Care, 27:17-20, 2004.
21 Lamacraft et al., "Subcutaneous cannulae for morphine boluses in children: assessment of a technique," J. Pain Symptom Manage., 13:43-9, 1997.
22 Liu et al., "Insulin absorption is faster when keeping the infusion site in use for three days during continuous subcutaneous insulin infusion." Diabetes Res. Clin. Pract., 12:19-24, 1991.
23 Long and Hughes,. "Indwelling cannula for insulin administration in diabetes mellitus." Arch. Dis. Child, 66:348-9, 1991.
24 McGrath et al., "A new analogue scale for assessing children's pain: an initial validation study," Pain, Mar; 64:435-43, 1996.
25 Office Action in U.S. Appl. No. 10/188,591, dated Dec. 15, 2005.
26 Office Action in U.S. Appl. No. 10/188,591, dated Dec. 15, 2006.
27 Office Action in U.S. Appl. No. 10/188,591, dated Feb. 27, 2006.
28 Office Action in U.S. Appl. No. 10/188,591, dated Jun. 7, 2006.
29 Office Action in U.S. Appl. No. 10/188,591, dated May 30, 2007.
30 Office Action in U.S. Appl. No. 10/188,591, dated Sep. 20, 2006.
31 Office Action in U.S. Appl. No. 11/372,681, dated Aug. 24, 2007.
32 Office Action in U.S. Appl. No. 11/372,681, dated Aug. 25, 2006.
33 Office Action in U.S. Appl. No. 11/372,681, dated Aug. 6, 2009.
34 Office Action in U.S. Appl. No. 11/372,681, dated Dec. 16, 2010.
35 Office Action in U.S. Appl. No. 11/372,681, dated Dec. 27, 2007.
36 Office Action in U.S. Appl. No. 11/372,681, dated Feb. 20, 2009.
37 Office Action in U.S. Appl. No. 11/372,681, dated Feb. 23, 2007.
38 Office Action in U.S. Appl. No. 11/372,681, dated May 1, 2008.
39 Office Action in U.S. Appl. No. 11/372,681, dated May 6, 2010.
40 Office Action in U.S. Appl. No. 11/372,681, dated Nov. 20, 2009.
41 Office Action in U.S. Appl. No. 11/372,681, dated Sep. 12, 2008.
42 Office Action in U.S. Appl. No. 11/466,349 dated Jun. 12, 2009.
43 Office Action in U.S. Appl. No. 11/466,349, dated May 4, 2011.
44 Office Action in U.S. Appl. No. 11/466,349, dated Nov. 6, 2009.
45 Office Action in U.S. Appl. No. 11/482,265, dated Apr. 3, 2008.
46 Office Action in U.S. Appl. No. 11/482,265, dated Aug. 25, 2006.
47 Office Action in U.S. Appl. No. 11/482,265, dated Dec. 11, 2007.
48 Office Action in U.S. Appl. No. 11/482,265, dated Dec. 16, 2010.
49 Office Action in U.S. Appl. No. 11/482,265, dated Jan. 12, 2009.
50 Office Action in U.S. Appl. No. 11/482,265, dated Jun. 10, 2010.
51 Office Action in U.S. Appl. No. 11/482,265, dated May 29, 2009.
52 Office Action in U.S. Appl. No. 11/482,265, dated May 30, 2007.
53 Office Action in U.S. Appl. No. 11/482,265, dated Nov. 17, 2009.
54 Office Action in U.S. Appl. No. 11/482,265, dated Nov. 30, 2006.
55 Office Action in U.S. Appl. No. 11/483,218, dated Apr. 8, 2008.
56 Office Action in U.S. Appl. No. 11/483,218, dated Aug. 25, 2006.
57 Office Action in U.S. Appl. No. 11/483,218, dated Jul. 27, 2007.
58 Office Action in U.S. Appl. No. 11/483,218, dated Mar. 26, 2007.
59 Office Action in U.S. Appl. No. 11/483,218, dated Nov. 30, 2006.
60 Office Action in U.S. Appl. No. 11/483,219, dated Apr. 3, 2008.
61 Office Action in U.S. Appl. No. 11/483,219, dated Aug. 11, 2006.
62 Office Action in U.S. Appl. No. 11/483,219, dated Dec. 11, 2007.
63 Office Action in U.S. Appl. No. 11/483,219, dated Dec. 16, 2010.
64 Office Action in U.S. Appl. No. 11/483,219, dated Jan. 12, 2009.
65 Office Action in U.S. Appl. No. 11/483,219, dated Jun. 9, 2010.
66 Office Action in U.S. Appl. No. 11/483,219, dated May 29, 2009.
67 Office Action in U.S. Appl. No. 11/483,219, dated May 30, 2007.
68 Office Action in U.S. Appl. No. 11/483,219, dated Nov. 17, 2009.
69 Office Action in U.S. Appl. No. 11/483,219, dated Nov. 30, 2006.
70 Office Action in U.S. Appl. No. 11/532,747, dated Dec. 27, 2007.
71 Office Action in U.S. Appl. No. 11/532,747, dated Jun. 30, 2008.
72 Office Action in U.S. Appl. No. 11/532,747, dated Mar. 18, 2009.
73 Office Action in U.S. Appl. No. 11/532,747, dated Mar. 31, 2010.
74 Office Action in U.S. Appl. No. 11/532,747, dated Nov. 17, 2011.
75 Office Action in U.S. Appl. No. 11/532,747, dated Oct. 21, 2009.
76 Office Action in U.S. Appl. No. 11/532,747, dated Oct. 8, 2008.
77 Office Action in U.S. Appl. No. 11/532,772, dated Apr. 28, 2010.
78 Office Action in U.S. Appl. No. 11/532,772, dated Jan. 12, 2011.
79 Office Action in U.S. Appl. No. 11/532,772, dated Jun. 2, 2009.
80 Office Action in U.S. Appl. No. 11/532,772, dated Nov. 12, 2008.
81 Office Action in U.S. Appl. No. 11/532,772, dated Oct. 23, 2009.
82 Office Action in U.S. Appl. No. 11/532,824, dated Apr. 1, 2009.
83 Office Action in U.S. Appl. No. 11/532,824, dated May 12, 2010.
84 Office Action in U.S. Appl. No. 11/532,824, dated Oct. 22, 2009.
85 Office Action in U.S. Appl. No. 11/532,836, dated Aug. 6, 2009.
86 Office Action in U.S. Appl. No. 11/532,836, dated Feb. 20, 2009.
87 Office Action in U.S. Appl. No. 11/532,836, dated Jan. 11, 2011.
88 Office Action in U.S. Appl. No. 11/532,836, dated Jan. 29, 2008.
89 Office Action in U.S. Appl. No. 11/532,836, dated Jun. 27, 2008.
90 Office Action in U.S. Appl. No. 11/532,836, dated May 20, 2010.
91 Office Action in U.S. Appl. No. 11/532,836, dated Nov. 19, 2009.
92 Office Action in U.S. Appl. No. 11/532,836, dated Sep. 17, 2008.
93 Office Action in U.S. Appl. No. 11/532,845, dated Apr. 9, 2009.
94 Office Action in U.S. Appl. No. 11/532,845, dated Oct. 30, 2009.
95 Office Action in U.S. Appl. No. 11/532,858, dated Apr. 9, 2009.
96 Office Action in U.S. Appl. No. 11/532,858, dated Oct. 30, 2009.
97 Office Action in U.S. Appl. No. 12/042,206, dated Mar. 23, 2011.
98 Office Action in U.S. Appl. No. 12/042,206, dated Sep. 20, 2010.
99 Office Action in U.S. Appl. No. 12/042,212, dated Jan. 18, 2011.
100 Office Action issued in Chinese Application No. 2006800475377, dated Oct. 29, 2010.
101 Office Action issued in Chinese Patent Application No. 200680038075.2, dated Nov. 23, 2010.
102 Office Action issued in New Zealand Patent Application No. 566773, dated Oct. 9, 2009.
103 Office Action issued in New Zealand Patent Application No. 567891, dated Nov. 9, 2009.
104 Office Action issued in Russian Application No. 2008110940, dated Jun. 11, 2010.
105 Office Action issued in Russian Patent Application No. 2008122063, dated Oct. 5, 2010.
106 Response to Office Action in U.S. Appl. No. 10/188,591, dated Jan. 19, 2006.
107 Response to Office Action in U.S. Appl. No. 10/188,591, dated Mar. 13, 2006.
108 Response to Office Action in U.S. Appl. No. 10/188,591, dated Mar. 15, 2007.
109 Response to Office Action in U.S. Appl. No. 10/188,591, dated Sep. 1, 2006.
110 Response to Office Action in U.S. Appl. No. 10/188,591, dated Sep. 26, 2006.
111 Response to Office Action in U.S. Appl. No. 10/188,591, dated Sep. 28, 2007.
112 Response to Office Action in U.S. Appl. No. 11/372,681, dated Apr. 12, 2011.
113 Response to Office Action in U.S. Appl. No. 11/372,681, dated Aug. 1, 2008.
114 Response to Office Action in U.S. Appl. No. 11/372,681, dated Dec. 18, 2008.
115 Response to Office Action in U.S. Appl. No. 11/372,681, dated Jun. 25, 2007.
116 Response to Office Action in U.S. Appl. No. 11/372,681, dated Mar. 20, 2008.
117 Response to Office Action in U.S. Appl. No. 11/372,681, dated Mar. 22, 2010.
118 Response to Office Action in U.S. Appl. No. 11/372,681, dated May 20, 2009.
119 Response to Office Action in U.S. Appl. No. 11/372,681, dated Nov. 26, 2007.
120 Response to Office Action in U.S. Appl. No. 11/372,681, dated Nov. 27, 2006.
121 Response to Office Action in U.S. Appl. No. 11/372,681, dated Nov. 5, 2010.
122 Response to Office Action in U.S. Appl. No. 11/372,681, dated Sep. 8, 2009.
123 Response to Office Action in U.S. Appl. No. 11/466,349, dated Mar. 8, 2010.
124 Response to Office Action in U.S. Appl. No. 11/466,349, dated Sep. 14, 2009.
125 Response to Office Action in U.S. Appl. No. 11/482,265, dated Apr. 12, 2011.
126 Response to Office Action in U.S. Appl. No. 11/482,265, dated Apr. 13, 2009.
127 Response to Office Action in U.S. Appl. No. 11/482,265, dated Apr. 19, 2010.
128 Response to Office Action in U.S. Appl. No. 11/482,265, dated Aug. 31, 2009.
129 Response to Office Action in U.S. Appl. No. 11/482,265, dated Feb. 28, 2007.
130 Response to Office Action in U.S. Appl. No. 11/482,265, dated Mar. 20, 2008.
131 Response to Office Action in U.S. Appl. No. 11/482,265, dated Nov. 9, 2010.
132 Response to Office Action in U.S. Appl. No. 11/482,265, dated Oct. 3, 2008.
133 Response to Office Action in U.S. Appl. No. 11/482,265, dated Sep. 12, 2007.
134 Response to Office Action in U.S. Appl. No. 11/482,265, dated Sep. 15, 2006.
135 Response to Office Action in U.S. Appl. No. 11/483,218, dated Aug. 4, 2008.
136 Response to Office Action in U.S. Appl. No. 11/483,218, dated Feb. 28, 2007.
137 Response to Office Action in U.S. Appl. No. 11/483,218, dated May 10, 2007.
138 Response to Office Action in U.S. Appl. No. 11/483,218, dated Sep. 15, 2006.
139 Response to Office Action in U.S. Appl. No. 11/483,219, dated Apr. 12, 2011.
140 Response to Office Action in U.S. Appl. No. 11/483,219, dated Apr. 13, 2009.
141 Response to Office Action in U.S. Appl. No. 11/483,219, dated Apr. 19, 2010.
142 Response to Office Action in U.S. Appl. No. 11/483,219, dated Aug. 31, 2009.
143 Response to Office Action in U.S. Appl. No. 11/483,219, dated Feb. 28, 2007.
144 Response to Office Action in U.S. Appl. No. 11/483,219, dated Mar. 20, 2008.
145 Response to Office Action in U.S. Appl. No. 11/483,219, dated Nov. 9, 2010.
146 Response to Office Action in U.S. Appl. No. 11/483,219, dated Oct. 3, 2008.
147 Response to Office Action in U.S. Appl. No. 11/483,219, dated Sep. 12, 2007.
148 Response to Office Action in U.S. Appl. No. 11/483,219, dated Sep. 15, 2006.
149 Response to Office Action in U.S. Appl. No. 11/532,747, dated Apr. 12, 2011.
150 Response to Office Action in U.S. Appl. No. 11/532,747, dated Aug. 4, 2008.
151 Response to Office Action in U.S. Appl. No. 11/532,747, dated Jul. 17, 2009.
152 Response to Office Action in U.S. Appl. No. 11/532,747, dated Mar. 20, 2008.
153 Response to Office Action in U.S. Appl. No. 11/532,747, dated Mar. 22, 2010.
154 Response to Office Action in U.S. Appl. No. 11/532,747, dated Mar. 9, 2009.
155 Response to Office Action in U.S. Appl. No. 11/532,747, dated Sep. 30, 2010.
156 Response to Office Action in U.S. Appl. No. 11/532,772, dated Apr. 11, 2011.
157 Response to Office Action in U.S. Appl. No. 11/532,772, dated Mar. 12, 2009.
158 Response to Office Action in U.S. Appl. No. 11/532,772, dated Mar. 23, 2010.
159 Response to Office Action in U.S. Appl. No. 11/532,772, dated Oct. 28, 2010.
160 Response to Office Action in U.S. Appl. No. 11/532,772, dated Sep. 8, 2009.
161 Response to Office Action in U.S. Appl. No. 11/532,824, dated Jul. 1, 2009.
162 Response to Office Action in U.S. Appl. No. 11/532,824, dated Mar. 22, 2010.
163 Response to Office Action in U.S. Appl. No. 11/532,824, dated Oct. 12, 2010.
164 Response to Office Action in U.S. Appl. No. 11/532,836, dated Apr. 12, 2011.
165 Response to Office Action in U.S. Appl. No. 11/532,836, dated Apr. 19, 2010.
166 Response to Office Action in U.S. Appl. No. 11/532,836, dated Aug. 4, 2008.
167 Response to Office Action in U.S. Appl. No. 11/532,836, dated Dec. 17, 2008.
168 Response to Office Action in U.S. Appl. No. 11/532,836, dated Mar. 20, 2008.
169 Response to Office Action in U.S. Appl. No. 11/532,836, dated May 20, 2009.
170 Response to Office Action in U.S. Appl. No. 11/532,836, dated Nov. 22, 2010.
171 Response to Office Action in U.S. Appl. No. 11/532,836, dated Sep. 8, 2009.
172 Response to Office Action in U.S. Appl. No. 11/532,845, dated Feb. 1, 2010.
173 Response to Office Action in U.S. Appl. No. 11/532,845, dated Jul. 9, 2009.
174 Response to Office Action in U.S. Appl. No. 11/532,858, dated Feb. 1, 2010.
175 Response to Office Action in U.S. Appl. No. 11/532,858, dated Jul. 9, 2009.
176 Response to Office Action in U.S. Appl. No. 12/042,206, dated Jan. 20, 2011.
177 Response to Office Action in U.S. Appl. No. 12/042,212, dated Apr. 18, 2011.
178 Selam and Charles, "Devices for insulin administration." Diabetes Care, 13:955-79, 1990.
179 Su et al., "The Relationship between Regimen Burden and Psychological Well Being in Persons with Type 1 Diabetes: Inhaled vs Injectable Insulin," American Diabetes Association 62nd Annual Meeting and Scientific Sessions, San Francisco, CA, Jun. 14-18, 2002 (Abstract No. 1843-P, p. A448).
180 Taddio et al., "Use of lidocaine-priolcaine cream for vaccination pain in infants," J. Pediatr., 124:643-648, 1994.
181 Testa et al., "Patient satisfaction with insulin therapy in type 2 diabetes: a randomized trial of injectable vs. inhaled insulin." American Diabetes Association 62nd Annual Meeting and Scientific Sessions, Jun. 14-18, 2002, San Francisco, CA, US.
182 U.S. Appl. No. 11/466,349, filed Aug. 22, 2006, Burns.
183 Zambanini et al., "Injection related anxiety in insulin-treated diabetes." Diabetes Res. Clin. Pract., 46:239-46, 1999.
US9039660 * Jul 24, 2012 May 26, 2015 Medtronic Minimed, Inc. Fluid delivery devices, systems and methods
US20130023834 * Jul 24, 2012 Jan 24, 2013 Brandon Turner Fluid Delivery Devices, Systems and Methods
USD794184 * Mar 11, 2016 Aug 8, 2017 Laborie Medical Technologies, Corp. Catheter connector
Cooperative Classification A61M39/04, A61M5/16804, A61M5/162, A61M5/1582, A61M5/3202, A61M2005/1581, A61K9/0021, A61M2005/1587, A61K9/0019, A61M5/158
European Classification A61M39/04, A61K9/00M5, A61K9/00M5B
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TURNER, BRANDON;BURNS, JOHN;BENZON, DAN;AND OTHERS;REEL/FRAME:018931/0532;SIGNING DATES FROM 20061221 TO 20070103
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TURNER, BRANDON;BURNS, JOHN;BENZON, DAN;AND OTHERS;SIGNING DATES FROM 20061221 TO 20070103;REEL/FRAME:018931/0532
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PATTON MEDICAL DEVICES, LP;REEL/FRAME:032640/0163